Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three distinct medications:\n\n1. N-acetylcysteine (NAC): An antioxidant medication primarily used as an antidote for acetaminophen overdose. It works by replenishing glutathione levels, the body's major antioxidant. NAC also has mucolytic properties, breaking up mucus in the lungs and airways.\n\n2. Calcitriol: The active form of vitamin D that helps regulate calcium and phosphorus metabolism.\n\n3. Hydroxychloroquine: An antimalarial and disease-modifying anti-rheumatic drug (DMARD) used to treat autoimmune conditions like lupus and rheumatoid arthritis. It's thought to work by interfering with immune system communication.\n\nThis specific combination does not appear to be a standard formulation with established clinical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-acetylcysteine + calcitriol + hydroxychloroquine.